Inspire Medical Systems, Inc.
INSP
$52.07
-$0.09-0.17%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 19.86% | 3.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 19.86% | 3.42% | |||
| Cost of Revenue | 13.53% | -8.36% | |||
| Gross Profit | 20.90% | 5.65% | |||
| SG&A Expenses | 1.94% | -0.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.77% | -2.52% | |||
| Operating Income | 378.13% | 390.83% | |||
| Income Before Tax | 271.33% | 681.09% | |||
| Income Tax Expenses | -2,470.02% | 187.22% | |||
| Earnings from Continuing Operations | 1,270.22% | 376.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1,270.22% | 376.50% | |||
| EBIT | 378.13% | 390.83% | |||
| EBITDA | 274.84% | 13,492.86% | |||
| EPS Basic | 1,288.66% | 378.23% | |||
| Normalized Basic EPS | 166.52% | 932.78% | |||
| EPS Diluted | 1,277.02% | 378.23% | |||
| Normalized Diluted EPS | 166.36% | 923.69% | |||
| Average Basic Shares Outstanding | -1.33% | -0.59% | |||
| Average Diluted Shares Outstanding | -1.29% | 0.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||